4D Molecular Therapeutics, Inc. (FDMT) stock
FDMTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/302% above fair value
$12.12−0.88 (-6.74%)
Close on Nov 12, 2026Market cap $874.46MP/E –Yield –
4D Molecular Therapeutics statistics
74 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Q3 FY2026, expected soon
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 11, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.77
- 2.38
Enterprise valuationIndustry
- EV / Sales
- 6.77
- 2.65
Share statisticsIndustry
- Shares Change (YoY)
- 22.9%
- 10.9%
- Shares Change (QoQ)
- 2.10%
- 0.48%
- Float
- 71M
- 49M
- Shares Held by Insiders
- 2.10%
- 12.1%
- Shares Held by Institutions
- 80.5%
- 56.4%
Short sellingIndustry
- Short Interest
- 11M
- –
- Short Interest Change
- -5.49%
- -0.80%
- Short % of Float
- 15.4%
- 9.06%
- Short % of Shares Outstanding
- 15.1%
- 6.30%
- Days to Cover
- 10.43
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $16.93
- –
- 52-Week Low
- $6.96
- –
- 20-Day Moving Average
- $12.16
- –
- 50-Day Moving Average
- $13.25
- –
- 200-Day Moving Average
- $11.04
- –
- Average True Range (14)
- $0.91
- –
- Price Change (1 Week)
- 5.78%
- -0.58%
- Price Change (1 Month)
- 5.10%
- -0.28%
- Price Change (3 Months)
- 11.5%
- -17.1%
- Price Change (6 Months)
- 24.3%
- -20.1%
- Price Change (YTD)
- 73.2%
- -20.1%
- Price Change (1 Year)
- 27.7%
- -19.3%
- Price Change (3 Years)
- 23.4%
- -22.2%
- Price Change (5 Years)
- -48.0%
- -76.4%
- Average Volume (10 Days)
- 915,663
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 935,054
- –
- Relative Volume
- 0.90
- 0.73
- Relative Strength Index (14)
- 53.6
- 47.7
- Volatility (1 Year)
- 77.0%
- 80.2%
- Beta (5 Years)
- 1.35
- 1.08
MarginsIndustry
- EBITDA Margin
- -220.9%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- -56.7%
- -51.3%
- Return on Assets (ROA)
- -47.0%
- -40.7%
- Return on Invested Capital (ROIC)
- -299.5%
- -32.9%
- Return on Capital Employed (ROCE)
- -57.7%
- -38.1%
Financial positionIndustry
- Current Ratio
- 6.15
- 3.30
- Quick Ratio
- 5.86
- 2.40
- Debt / Equity
- 0.06
- 0.50
GrowthIndustry
- Revenue Growth (YoY)
- 79952.5%
- 7.26%
- Revenue Growth (3Y CAGR)
- 200.9%
- 2.25%
- Revenue Growth (5Y CAGR)
- 44.3%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.23
- 0.40
- Revenue Per Employee
- $490.12K
- $429.38K
- Profits Per Employee
- -$1.02M
- -$683.67K
- Employee Count
- 196
- 75
- WACC
- 11.5%
- 10.1%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $287.31M
- $16.56M
- Net Cash Per Share
- $3.98
- $0.71
- Equity (Book Value)
- $337.94M
- $52.23M
- Book Value Per Share
- $4.68
- $1.50
- Tangible Book Value
- $337.94M
- $26.10M
- Working Capital
- $269.89M
- $78.41M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -21.4%
- -20.1%
Taxes and interestIndustry
- Income Tax
- $0
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- 2.45
- 0.31
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | FDMT | S&P 500 | Difference | FDMT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -6.8% | -2.7% | −4.1 pts | ||
| 3 months | +2.1% | -1.7% | +3.8 pts | ||
| Year to date | +61.5% | +11.9% | +49.6 pts | ||
| 1 year | +10.4% | +12.0% | −1.5 pts | ||
| 3 years | +9.6% | +78.2% | −68.5 pts | +3.1% | +21.2% |
| 5 years | -51.5% | +73.2% | −124.7 pts | -13.5% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
11M FDMT shares were sold short on Oct 30, 2026, down 5.5% from the previous report, or 15.42% of the shares available to trade. At recent volumes it would take 10.4 days to buy them back. Over the last 20 sessions, 54.1% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 10,897,478 | -5.5% | 1,045,170 | 10.4 |
| Oct 15, 2026 | 11,530,134 | +2.6% | 960,955 | 12.0 |
| Sep 30, 2026 | 11,238,611 | -6.4% | 1,204,980 | 9.3 |
| Sep 15, 2026 | 12,008,645 | -0.5% | 647,409 | 18.6 |
| Aug 31, 2026 | 12,069,229 | -1.8% | 1,481,002 | 8.2 |
| Aug 14, 2026 | 12,289,621 | +2.1% | 550,714 | 22.3 |
| Jul 31, 2026 | 12,038,453 | +5.9% | 680,478 | 17.7 |
| Jul 15, 2026 | 11,363,434 | -14.6% | 732,623 | 15.5 |
| Jun 30, 2026 | 13,305,097 | +2.9% | 1,461,960 | 9.1 |
| Jun 15, 2026 | 12,929,459 | +6.0% | 782,378 | 16.5 |
| May 29, 2026 | 12,191,854 | +0.9% | 872,663 | 14.0 |
| May 15, 2026 | 12,081,925 | +0.8% | 633,230 | 19.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?